CIDRAP newsletters options
In other developments, top health officials from 10 African nations met in the DRC today and agreed on a joint preparedness framework.
A new study in Nature Medicine offers the first clear evidence of enterovirus (EV) in the cerebrospinal fluids of patients with acute flaccid myelitis (AFM) – a mysterious, polio-like illness that can cause paralysis in otherwise healthy children.
A study today in Infection Control & Hospital Epidemiology has determined that an electronic best practice advisory combined with prescriber education was associated with reduced antibiotic prescribing for adults with acute bronchitis.
Of 10 million people estimated to have TB in 2018, 7 million were diagnosed, meeting a recent UN goal.
In other Ebola developments today, three newly confirmed cases were reported in the outbreak region.
The Food and Drug Administration (FDA) approved the use single-dose Xofluza (baloxavir marboxil) for patients ages 12 and over who are at high risk for influenza complications. Xofluza should only be administered to patients who have been symptomatic for 48 hours or less.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Oct 17
Coverage for 3 key childhood vaccines remains near 95% but varies by state, the CDC says.
Today the Democratic Republic of the Congo (DRC) confirmed one new case of Ebola in the ongoing outbreak in North Kivu and Ituri provinces, but the World Health Organization (WHO) spotlighted some troubling signs in its weeks update.
In a 14-2 vote, the US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee yesterday recommended that the new antibiotic cefiderocol, made by Shionogi & Co, Ltd, of Japan, be approved for complicated urinary tract infection (cUTI), including pyelonephritis, caused by gram-negative bacteria in patients who have limited or no alternative treatment options available, the company said in a news r
Recent cases have been in a compact area with limited access and security problems.
Yesterday three of the nation's biggest health organizations—the American Lung Association, the American Diabetes Association, and the American Heart Association—recommended that Americans living with chronic health conditions get this year's seasonal influenza vaccine.
The US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee is meeting today to discuss the new drug application (NDA) for cefiderocol, an investigational antibiotic developed by Shionogi, Inc, a US-based subsidiary of Japanese pharmaceutical company Shionogi & Co.
Outbreak totals climb to 3,224 infections, including 2,150 fatal ones.
Though declines are not consistent across countries, antibiotic sales are down 32.5% since 2011.
As the Southern Hemisphere nears the end of its typical flu season, influenza activity continues to decline, with a second wave of activity in Chile—mainly from influenza B—slowing, the World Health Organization (WHO) said in its latest global flu update.
The Johnson & Johnson Ebola vaccine will be rolled out in November, officials say.
Saudi Arabia's Ministry of Health (MOH) this weekend reported three new MERS-CoV infections, bringing the total for the month to six.
The first MERS-CoV (Middle East respiratory syndrome coronavirus) case involves an 80-year-old man in Buraydah in the north-central part of the country, the MOH said on Oct 12. Officials listed his case as "primary," meaning it's unlikely he contracted the disease from another MERS patient.
The WHO continues to say that progress in curtailing the outbreak must be balanced with caution.
In its latest weekly update, the Global Polio Eradication Initiative (GPEI) said today that Pakistan recorded three new cases of wild poliovirus type 1 (WPV1) this week, and the Democratic Republic of the Congo (DRC) and the Central African Republic recorded new cases of vaccine-derived poliovirus type 2 (cVDPV2).
